A Prospective Randomized Trial of ECP in Subclinical AMR

NARecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2027

Study Completion Date

June 1, 2027

Conditions
Antibody-mediated RejectionLung Transplant Rejection
Interventions
PROCEDURE

Extracorporeal Photopheresis

Patients randomized into the interventional group will receive ECP. ECP will be started within one week after randomization. Initially a two-day treatment cycle will be performed once every second week for the first two months. Then, a two-day treatment cycle will be performed once a month for 6 months.

Trial Locations (7)

1090

RECRUITING

Medical University of Vienna, Vienna

Unknown

NOT_YET_RECRUITING

UZ Leuven, Leuven

NOT_YET_RECRUITING

University Hospital Center Zagreb, Zagreb

NOT_YET_RECRUITING

Copenhagen University Hospital, Rigshospitalet, Copenhagen

NOT_YET_RECRUITING

Hôpital Foch, Suresnes

NOT_YET_RECRUITING

Policlinico San Matteo Pavia Fondazione IRCCS, Pavia

NOT_YET_RECRUITING

University Medical Centre Ljubljana, Ljubljana

All Listed Sponsors
lead

Medical University of Vienna

OTHER